18 Platelet transfusion remains the mainstay of therapy for perioperative thrombocytopenia, but can be ineffective in selected populations, have most of the risks of blood product transfusion, and they are a scarce source.19 With successful TPO-RA cure, people with recognized thrombocytopenia undergoing elective procedures could endure pharmacologic platelet count optimization https://eddieq631glp3.wikiannouncement.com/user